Earth Science Tech Inc. (OTC: ETST), a strategic holding company in the healthcare, pharmacy, and telemedicine sector, has completed the acquisition of Zoolzy LLC, a wholesale distributor of active pharmaceutical ingredients (APIs) and finished FDA-approved prescription products. Based in Doral, Florida, where it operates from a 3,684-square-foot facility, Zoolzy’s distribution capabilities are now integrated into ETST’s operations, marking a significant step in the company’s growth strategy.
This acquisition delivers value across three growth drivers: expanding overall profit margins, broadening access to new ingredients, and enabling entry into the veterinary market. By securing essential raw materials at highly competitive wholesale pricing, ETST’s compounding pharmacies can significantly increase their profit margins. The move also expands the company’s access to a wider range of APIs, which is crucial for developing new formulations and meeting diverse patient needs.
Furthermore, the acquisition opens the door to the veterinary market, a complementary vertical that aligns with ETST’s existing healthcare focus. This strategic diversification allows the company to leverage its pharmacy and telehealth infrastructure to serve animal health, a growing sector with increasing demand for compounded medications.
The acquisition represents Earth Science Tech’s move to seize strategic opportunities that broaden its telehealth and pharmacy fulfillment platforms into new, complementary verticals. According to the company, this integration supports its compounding pharmacies by ensuring a reliable supply chain for raw materials, reducing costs, and enhancing operational efficiency. The addition of Zoolzy’s distribution network is expected to create synergies that drive long-term shareholder value.
Earth Science Tech has been actively expanding its footprint in the healthcare industry, and this acquisition underscores its commitment to innovation and growth. By diversifying its revenue streams and strengthening its supply chain, ETST is better positioned to navigate the evolving healthcare landscape and meet the demands of its customers.
Investors and industry observers will be watching to see how this acquisition impacts ETST’s financial performance in the coming quarters. The company’s strategic focus on high-margin opportunities and market expansion is likely to attract attention from stakeholders seeking exposure to the growing telemedicine and pharmaceutical sectors.
For more information on Earth Science Tech and its recent developments, visit the company’s newsroom at https://ibn.fm/ETST.
